West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. (WST) Revenue
Annual & quarterly revenue history · segment & region breakdown
WST · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsWest Pharmaceutical Services, Inc. trailing twelve-month (TTM) revenue is $3.22B, an increase of 6.26% year-over-year from $3.07B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $3.07B | +$0.18B | +6.26% |
| 2024-12-31 | $2.89B | -$0.06B | -1.98% |
| 2023-12-31 | $2.95B | +$0.07B | +2.27% |
| 2022-12-31 | $2.89B | +$0.05B | +1.94% |
| 2021-12-31 | $2.83B | +$0.68B | +31.86% |
| 2020-12-31 | $2.15B | +$0.30B | +16.44% |
| 2019-12-31 | $1.84B | +$0.13B | +7.31% |
| 2018-12-31 | $1.72B | +$0.12B | +7.36% |
| 2017-12-31 | $1.60B | +$0.09B | +6.04% |
| 2016-12-31 | $1.51B | +$0.11B | +7.95% |
Compare revenue vs peers
Medical - Instruments & SuppliesCompare WST revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income West Pharmaceutical Services, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
West Pharmaceutical Services, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from West Pharmaceutical Services, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
WST revenue · 4 questionsWST's trailing twelve-month (TTM) revenue is $3.22B. That is an increase of 6.26% year-over-year from $3.07B in FY2025.
▸ Source: FMP · West Pharmaceutical Services, Inc. SEC filings · GAAP · West Pharmaceutical Services, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026